Akums Drugs & Pharmaceuticals shares are trading at Rs. 915.00, marking a small increase of 0.25 points or 0.03% from the previous close of Rs. 914.75 on the BSE.

The stock opened at Rs. 896.00, hitting a day’s high of Rs. 935.00 and a low of Rs. 896.00. A total of 17,573 shares have been exchanged so far.

This 'B' group stock, with a face value of Rs. 2, reached a 52-week high of Rs. 1,174.85 on August 20, 2024, and a 52-week low of Rs. 724.50 on August 6, 2024.

In the past week, the stock peaked at Rs. 935.00 and bottomed out at Rs. 815.00. The company's market capitalization currently stands at Rs. 14,355.12 crore.

The company’s ownership breakdown shows that promoters hold 75.26%, while institutions and non-institutional investors own 14.58% and 10.16% respectively.

Akums Drugs & Pharmaceuticals has signed a Memorandum of Understanding (MoU) with the Zambian Government’s Ministry of Health, located at Ndeke House in Lusaka, for local medicine manufacturing. The agreement also highlights the ongoing collaboration in the field of medicines and medical supplies and aims to further strengthen the relationship between the two entities.

Akums is a prominent contract development and manufacturing organization (CDMO), offering a wide array of pharmaceutical products and services both in India and globally.